Filtered By:
Source: American Journal of Translational Research
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 412 results found since Jan 2013.
Downregulation of miR-145 alleviates ox-LDL-induced inflammation by targeting QKI in macrophages
CONCLUSION: miR-145 regulates the inflammatory response induced by macrophage activation through targeting QKI. It provides a means for AS targeted therapy.PMID:35836907 | PMC:PMC9274569
Source: American Journal of Translational Research - July 15, 2022 Category: Research Authors: Xueqiang Feng Fuwang Yao Yuqin Lang Zhibin Cao Source Type: research
LAP+CD4+T cells regulate the anti-tumor role of CIK cells in colorectal cancer through IL-10 and TGF- β
Am J Transl Res. 2022 Jun 15;14(6):3716-3728. eCollection 2022.ABSTRACTThe rate of colorectal cancer (CRC) is increasing. Adoptive immune cell therapy (ACT) is a research hotspot in CRC treatment, and the common adoptive cells are cytokine-induced killer cells (CIK). The problem of ACT is that some regulatory T cells (Treg) will affect the efficacy. Latent associated polypeptide (LAP)+CD4+T is a new Treg, and its immunosuppressive effect is much higher than that of traditional Tregs. This research mainly explored the influence of LAP+CD4+T cells on anti-tumor lethality of CIK cells, so as to fill this gap. The LAP+CD4+T CI...
Source: American Journal of Translational Research - July 15, 2022 Category: Research Authors: Wu Zhong Chuanfa Fang Hongquan Liu Lei Zhang Xiaofei Zhang Junqiao Zhong Xianping He Leichang Zhang Source Type: research
Downregulation of miR-145 alleviates ox-LDL-induced inflammation by targeting QKI in macrophages
CONCLUSION: miR-145 regulates the inflammatory response induced by macrophage activation through targeting QKI. It provides a means for AS targeted therapy.PMID:35836907 | PMC:PMC9274569
Source: American Journal of Translational Research - July 15, 2022 Category: Research Authors: Xueqiang Feng Fuwang Yao Yuqin Lang Zhibin Cao Source Type: research
LAP+CD4+T cells regulate the anti-tumor role of CIK cells in colorectal cancer through IL-10 and TGF- β
Am J Transl Res. 2022 Jun 15;14(6):3716-3728. eCollection 2022.ABSTRACTThe rate of colorectal cancer (CRC) is increasing. Adoptive immune cell therapy (ACT) is a research hotspot in CRC treatment, and the common adoptive cells are cytokine-induced killer cells (CIK). The problem of ACT is that some regulatory T cells (Treg) will affect the efficacy. Latent associated polypeptide (LAP)+CD4+T is a new Treg, and its immunosuppressive effect is much higher than that of traditional Tregs. This research mainly explored the influence of LAP+CD4+T cells on anti-tumor lethality of CIK cells, so as to fill this gap. The LAP+CD4+T CI...
Source: American Journal of Translational Research - July 15, 2022 Category: Research Authors: Wu Zhong Chuanfa Fang Hongquan Liu Lei Zhang Xiaofei Zhang Junqiao Zhong Xianping He Leichang Zhang Source Type: research
Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF- κB/STAT3 signaling pathway
CONCLUSION: AS-IV can inhibit the proliferative, invasive, and migratory ability of liver cancer through the suppression of the M2 polarization of macrophages, and the mechanism may involve the TLR4/NF-κB/STAT3 signaling pathway. The present study indicates that AS-IV could be an alternative drug to treat liver cancer, and the polarization of macrophages may be a novel treatment target for HCC.PMID:35422920 | PMC:PMC8991133
Source: American Journal of Translational Research - April 15, 2022 Category: Research Authors: Liang Min Haiqiao Wang Hong Qi Source Type: research
